9NNU: Ebola Envelope glycoprotein GP

Crystal Structure of Ebola Envelope glycoprotein GP in complex with compound LD4-189ZbR. Determined by X-ray diffraction at 2.59 Å resolution. Released 30 Jul 2025.

Method
X-ray diffraction
Resolution
2.59 Å
Organism
Ebola virus - Mayinga, Zaire, 1976
Chains
2
Atoms
3,006
Mol. weight
72.12 kDa
Ligands
NAG, A1BZF
Released
30 Jul 2025

Explore 9NNU in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

9NNU contains 13 α-helices and 29 β-strands across 2 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 8 helices, 25 β-strands

ElementResiduesLengthSheet
β-strand36-3941
β-strand42-4541
α-helix48-503
α-helix60-623
β-strand63-6971
α-helix70-734
α-helix79-846
β-strand86-8942
β-strand96-9831
β-strand10111
β-strand102-10323
β-strand105-114104
β-strand12014
α-helix1231
β-strand12415
α-helix125-1262
β-strand135-144104
β-strand151-15442
β-strand159-16131
β-strand165-16731
β-strand16912
β-strand17215
β-strand17614
β-strand177-18591
α-helix186-1872
β-strand216-22384
β-strand231-23554
β-strand240-24344
α-helix250-26314
β-strand273-27534
β-strand27716
β-strand308-31036
β-strand474-47636
Chain B: 5 helices, 4 β-strands
ElementResiduesLengthSheet
β-strand50311
β-strand515-52063
α-helix539-5413
β-strand543-54863
α-helix551-5533
α-helix554-57522
β-strand580-58121
α-helix584-59714
α-helix613-6197

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Envelope glycoproteinAprotein470Ebola virus - Mayinga, Zaire, 1976Q05320 (AlphaFold model)
GP2Bprotein168Ebola virus - Mayinga, Zaire, 1976Q05320 (AlphaFold model)
Sequence of entity 1 (A), FASTA
>9NNU_1 Envelope glycoprotein (chains A)
SIPLGVIHNSALQVSDVDKLVCRDKLSSTNQLRSVGLNLEGNGVATDVPSATKRWGFRSG
VPPKVVNYEAGEWAENCYNLEIKKPDGSECLPAAPDGIRGFPRCRYVHKVSGTGPCAGDF
AFHKEGAFFLYDRLASTVIYRGTTFAEGVVAFLILPQAKKDFFSSHPLREPVNATEDPSS
GYYSTTIRYQATGFGTNETEYLFEVDNLTYVQLESRFTPQFLLQLNETIYTSGKRSNTTG
KLIWKVNPEIDTTIGEWAFWETKKNLTRKIRSEELSFTVVSNGAKNISGQSPARTSSDPG
TNTTTEDHKIMASENSSAMVQVHSQGREAAVSHLTTLATISTSPQSLTTKPGPDNSTHNT
PVYKLDISEATQVEQHHRRTDNDSTASDTPSATTAAGPPKAENTNTSKSTDFLDPATTTS
PQNHSETAGNNNTHHQDTGEESASSGKLGLITNTIAGVAGLITGGRRTRR
Sequence of entity 2 (B), FASTA
>9NNU_2 GP2 (chains B)
EAIVNAQPKCNPNLHYWTTQDEGAAIGLAWIPYFGPAAEGIYIEGLMHNQDGLICGLRQL
ANETTQALQLFLRATTELRTFSILNRKAIDFLLQRWGGTCHILGPDCCIEPADWTKNITD
KIDQIIHDFVDGSGYIPEAPRDGQAYVRKDGEWVLLSTFLGTHHHHHH

Ligands and cofactors

IDNameFormulaCopies
NAG2-acetamido-2-deoxy-beta-D-glucopyranoseC8 H15 N O64
A1BZFN-{3-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1-phenylbut-1-en-2-yl]phenyl}-…C30 H37 N3 O4 S1

Primary citation

SuFEx-enabled high-throughput medicinal chemistry for developing potent tamoxifen analogs as Ebola virus entry inhibitors. Dada, L., Nagai, E., Agrawal, S. et al. Front Immunol (2025) 16:1533037-1533037. DOI 10.3389/fimmu.2025.1533037 · PubMed

Other PDB entries of the same protein (UniProt Q05320 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 9NNU directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.